Nephros (NEPH) Revenue (2010 - 2026)

Nephros has reported Revenue for 17 years, with the latest figure at $6.0 million in Q2 2026.

• On a quarterly basis, Revenue rose 36.16% year-over-year to $6.0 million in Q2 2026; TTM through Jun 2026 was $20.7 million, a 24.2% increase from a year earlier, with the FY2025 full-year figure at $18.8 million, up 32.67% from the prior year.
• Revenue was $6.0 million for Q2 2026 at Nephros, up from $5.2 million in the prior quarter.
• The five-year high for Revenue was $6.0 million in Q2 2026, with the low at $2.2 million in Q1 2022.
• Average Revenue over 5 years is $3.8 million, with a median of $3.6 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Revenue slipped 21.09% in 2022, then soared 71.24% in 2023.
• Over 5 years, Revenue stood at $2.6 million in 2022, then climbed by 27.21% to $3.3 million in 2023, then grew by 18.93% to $3.9 million in 2024, then climbed by 22.2% to $4.7 million in 2025, then advanced by 27.24% to $6.0 million in 2026.
• The last three Revenue figures came in at $6.0 million (Q2 2026), $5.2 million (Q1 2026), and $4.7 million (Q4 2025), per Business Quant data.